Tags

Type your tag names separated by a space and hit enter

Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
Bioorg Med Chem Lett. 2016 Feb 01; 26(3):889-893.BM

Abstract

In order to analyze the role of the phenolic OH moiety of ifenprodil (1) and 3-benzazepin-1,7-diol 2 for the affinity and selectivity at GluN2B subunit containing NMDA receptors, the 3-benzazepin-1-ols 3 were designed, synthesized and pharmacologically evaluated and furthermore, the molecular interactions of the phenylbutyl derivative 3c with the GluN2B receptor were investigated. In order to avoid decarbonylation during the intramolecular Friedel-Crafts acylation of 11, the N-atom has to be protected with a trifluoromethylsulfonyl group. The second key step of the synthesis was the removal of the N-triflyl group, which was realized by K2CO3 induced elimination of trifluoromethanelsulfinate (F3CSO2(-)). In receptor binding studies with the radioligand [(3)H]ifenprodil the 3-benzazepin-1-ol 3c revealed a GluN2B affinity of 73 nM indicating that the phenolic OH moiety of 1 and 2 is not essential but favorable for high GluN2B affinity. In docking studies 3-benzazepin-1-ol 3c shows the same binding pose as ifenprodil-keto 1A in the X-ray crystal structure. H-bond interactions and lipophilic interactions of 3c and 1A are very similar.

Authors+Show Affiliations

Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster, Corrensstraβe 48, D-48149 Münster, Germany; NRW Graduate School of Chemistry, Westfälischen Wilhelms-Universität Münster, Wilhelm-Klemm-Str. 10, D-48149 Münster, Germany.Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster, Corrensstraβe 48, D-48149 Münster, Germany; Cells-in-Motion Cluster of Excellence (EXC 1003-CiM), Westfälische Wilhelms-Universität Münster, Germany.Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster, Corrensstraβe 48, D-48149 Münster, Germany; Cells-in-Motion Cluster of Excellence (EXC 1003-CiM), Westfälische Wilhelms-Universität Münster, Germany. Electronic address: wuensch@uni-muenster.de.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26750254

Citation

Dey, Sougata, et al. "Role of the Phenolic OH Moiety of GluN2B-selective NMDA Antagonists With 3-benzazepine Scaffold." Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 3, 2016, pp. 889-893.
Dey S, Schepmann D, Wünsch B. Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold. Bioorg Med Chem Lett. 2016;26(3):889-893.
Dey, S., Schepmann, D., & Wünsch, B. (2016). Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold. Bioorganic & Medicinal Chemistry Letters, 26(3), 889-893. https://doi.org/10.1016/j.bmcl.2015.12.067
Dey S, Schepmann D, Wünsch B. Role of the Phenolic OH Moiety of GluN2B-selective NMDA Antagonists With 3-benzazepine Scaffold. Bioorg Med Chem Lett. 2016 Feb 1;26(3):889-893. PubMed PMID: 26750254.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold. AU - Dey,Sougata, AU - Schepmann,Dirk, AU - Wünsch,Bernhard, Y1 - 2015/12/21/ PY - 2015/11/23/received PY - 2015/12/17/revised PY - 2015/12/19/accepted PY - 2016/1/12/entrez PY - 2016/1/12/pubmed PY - 2016/10/16/medline KW - Conformational restriction KW - Docking KW - GluN2B selective NMDA receptor antagonist KW - N-Triflyl deprotection KW - NMDA receptor KW - Radioligand receptor binding studies KW - Tetrahydro-3-benzazepin-1-ol SP - 889 EP - 893 JF - Bioorganic & medicinal chemistry letters JO - Bioorg Med Chem Lett VL - 26 IS - 3 N2 - In order to analyze the role of the phenolic OH moiety of ifenprodil (1) and 3-benzazepin-1,7-diol 2 for the affinity and selectivity at GluN2B subunit containing NMDA receptors, the 3-benzazepin-1-ols 3 were designed, synthesized and pharmacologically evaluated and furthermore, the molecular interactions of the phenylbutyl derivative 3c with the GluN2B receptor were investigated. In order to avoid decarbonylation during the intramolecular Friedel-Crafts acylation of 11, the N-atom has to be protected with a trifluoromethylsulfonyl group. The second key step of the synthesis was the removal of the N-triflyl group, which was realized by K2CO3 induced elimination of trifluoromethanelsulfinate (F3CSO2(-)). In receptor binding studies with the radioligand [(3)H]ifenprodil the 3-benzazepin-1-ol 3c revealed a GluN2B affinity of 73 nM indicating that the phenolic OH moiety of 1 and 2 is not essential but favorable for high GluN2B affinity. In docking studies 3-benzazepin-1-ol 3c shows the same binding pose as ifenprodil-keto 1A in the X-ray crystal structure. H-bond interactions and lipophilic interactions of 3c and 1A are very similar. SN - 1464-3405 UR - https://www.unboundmedicine.com/medline/citation/26750254 DB - PRIME DP - Unbound Medicine ER -